- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03565562
Preventing Psychological Distress and Suicidal Behaviours: a Web-based and Mobile Suicide Prevention Intervention in the General Population (PRINTEMPS)
Study Overview
Status
Conditions
Detailed Description
- Context France is one of the Western European countries most affected by suicide, which is associated with a high societal cost. Recently, a European project aiming to develop best practice for suicide prevention has recommended the development of web-based interventions and the French national plan for actions against suicide has supported the development of reference websites for suicide prevention. However, web-based interventions should be associated with effective promotional efforts to ensure awareness but also to improve receptiveness among and around those who could benefit from such a resource. Previous work has shown that local authorities are appropriate actors for promoting prevention measures against suicide and that 20% of individuals attempting suicide visit their GP the day before their attempt.
- Research objectives The primary objective of our trial is to assess the effectiveness of the tailored promotion at local level of an e-health tool and to compare the effectiveness at 12 months of two types of local promotion (with or without involving GPs' waiting room) on suicidal acts. The secondary objectives are to assess the cost-effectiveness and to run a budgetary impact analysis of the intervention. Moreover, our secondary objectives are to assess the effectiveness of the promotion on the intensity of utilization of StopBlues by the three types of users (living in a city without promotion or with promotion or reinforced promotion), on their help-seeking behavior, on their implementation of supportive activities into their daily life and on the evolution of users level of psychological impairment. An additional form of promotion (intensively sustained promotion) will be implemented after 12 months in the control group and evaluated using the same primary outcome measure. In parallel, the long-term effectiveness of the two main types of local promotion (with or without a passive involvement of GPs through their waiting room) will also be assessed.
- Methodology The detailed content of the e-health tool and the promotional tools to be made available to local authorities and GPs was determined through literature reviews and focus groups with experts and users.
A cluster-randomized, parallel group, controlled intervention study with local authorities as the unit of randomization will be set up. Local authorities can either be cities or a grouping of cities ("communauté de communes"), based on the local health governance of each area. If several adjacent local authorities volunteer individually to participate in the trial, they will be considered as a unique local authority. Volunteer local authorities will be randomly assigned to one of the following three arms: those not promoting the e-health tool (control group); those promoting the e-health tool without involving GPs' waiting rooms; those promoting the e-health tool involving GPs' waiting rooms.
The trial will last 24 months and local authorities will be able to switch arm if they so wish after 12 months and launch an 'intensively sustained promotion'. This will facilitate recruitment of local authorities as well as their adherence to the intervention. Data will be collected both at the local authority level and at the individual user level.
• Expected results The investigators anticipate that the promotion of the e-health intervention will lead to a greater difference in the number of suicidal acts in the local authorities where it is implemented over the trial period. Furthermore, it should also result in a higher reduction of psychological distress and in an increased intensity and length of use of the e-health tool. The promotion may also lead members of the population with moderate level of psychological distress, who may not otherwise be seeking help, to access the e-health tool and should also facilitate help-seeking behaviors and implementation of supportive activities into their daily life. The intensively sustained promotion should lead to higher rates of connexion and by then to a higher reduction of psychological distress and in an increased intensity and length of use of the e-health tool.
Moreover, this project will give information on the relevance of our promotion model for primary prevention of psychological distress. Indeed, if the findings are satisfactory, this model and the formalized networks for promotion within local authorities may facilitate development of additional primary prevention measures both for mental disorders and other health issues.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Karine Chevreul, MD, PhD
- Phone Number: 003340274148
- Email: printemps@urc-eco.fr
Study Locations
-
-
-
Paris, France, 75010
- Recruiting
- Faculté de Médecine Paris Diderot Paris 7
-
Contact:
- Karine Chevreul, MD, PhD
- Phone Number: (0)140274148
- Email: karine.chevreul@urc-eco.fr
-
Contact:
- Kathleen Turmaine, MD
- Phone Number: (0)140275285
- Email: kathleen.turmaine@urc-eco.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- >18 years
- living in one of the 42 french local authority participating to the trial
- volunteer
- access to internet (smartphone/tablet/computer)
Exclusion Criteria:
- <18 years
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Control group
Local authorities allocated to this group won't implement any promotion of the e-health tool for the 12 first months.
Free access to StopBlues.
|
|
ACTIVE_COMPARATOR: Group experimental 1 promotion
Local authorities allocated to this group will have to implement the promotion of the e-health tool: the promotion at the local authority level.
They will promote the e-health tool using their usual communication methods (local newspapers, local website, bulletin and billboards, posters in the local shops and in the bus stops…).
Free access to StopBlues.
|
Local authorities participating in the trial will select a referent person who will be in charge of the implementation and follow-up of the promotion.
A promotion toolkit with recommendations, posters, web banners, leaflets and ready-made messages and press articles will be provided to the local authorities.
Other Names:
|
ACTIVE_COMPARATOR: Group experimental 2 promotion
Local authorities allocated to this group will have to implement promotion of the e-health tool: the promotion at local authority and GPs' waiting room level.
Local authorities will promote the e-health tool using their usual communication methods (local newspapers, local website, bulletin and billboards, posters in the local shops and in the bus stops...).
(similarly to group experimental1) as well as leaflets and posters in GPs' waiting room.
Free access to StopBlues.
|
Local authorities participating in the trial will select a referent person who will be in charge of the implementation and follow-up of the promotion.
A promotion toolkit with recommendations, posters, web banners, leaflets and ready-made messages and press articles will be provided to the local authorities.
Other Names:
In those local authorities, GPs will participate passively to the promotion of the e-health tool, by providing posters and leaflets in their waiting rooms.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of suicides - Short term
Time Frame: At month 9
|
The number of completed suicides will be extracted from the database of the Epidemiology center on medical causes of deaths (CépiDc) for each local authority participating.
|
At month 9
|
Number of suicide attempts - Short term
Time Frame: At month 9
|
The number of attempted suicides will be extracted from the national database of public and private hospital admissions (PMSI-MCO) and the national emergency database (Oscour).
|
At month 9
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of suicides - Long term
Time Frame: At the end of the trial (month 18)
|
The number of completed suicides will be extracted from the database of the Epidemiology center on medical causes of deaths (CépiDc) for each local authority participating.
|
At the end of the trial (month 18)
|
Number of suicide attempts - Long term
Time Frame: At the end of the trial (month 18)
|
The number of attempted suicides will be extracted from the national database of public and private hospital admissions (PMSI-MCO) and the national emergency database (Oscour).
|
At the end of the trial (month 18)
|
Costs
Time Frame: At 9 months and at the end of the trial (month 18)
|
Fixed costs for the development of the intervention including promotions tools, semi-fixed costs for the implementation of the program by local authorities and GPs, costs of suicidal acts.
|
At 9 months and at the end of the trial (month 18)
|
Level of health-related quality of life and associated utility of StopBlues users
Time Frame: At registration, and 1, 2, 3, 6, 12 and 18 months after
|
Collected through self-assessment at the user level with the quality of life questionnaire Short Form-12 (SF-12).
|
At registration, and 1, 2, 3, 6, 12 and 18 months after
|
Level of psychological pain of StopBlues users
Time Frame: At registration, and then at 1, 2, 3, 6, 12 and 18 months
|
Collected through self-assessment at the user level with the 12-item General Health Questionnaire (GHQ-12).
|
At registration, and then at 1, 2, 3, 6, 12 and 18 months
|
Level of depression of StopBlues users
Time Frame: At registration, and then at 1, 2, 3, 6, 12 and 18 months
|
Collected through self-assessment at the user level with the Patient Health Questionnaire (PHQ-9)
|
At registration, and then at 1, 2, 3, 6, 12 and 18 months
|
Level of anxiety of StopBlues users
Time Frame: At registration, and then at 1, 2, 3, 6, 12 and 18 months
|
Collected through self-assessment at the user level with the General Anxiety Disorder questionnaire (GAD-7).
|
At registration, and then at 1, 2, 3, 6, 12 and 18 months
|
Level of suicidal risk of StopBlues users
Time Frame: At first filling and 1, 2, 3, 6, 12 and 18 months after
|
Collected through self-assessment at the user level with the 6 questions on the suicidal risk of the Mini International Neuropsychiatric Interview-Simplified (MINI-S).
The MINI-S is not available at registration, it will be triggered when results to GHQ-12, PHQ-9 and/or GAD-7 are considered showing a suicidal risk for the user.
|
At first filling and 1, 2, 3, 6, 12 and 18 months after
|
Help-seeking behaviors and implementation of supportive activities into daily life of StopBlues users
Time Frame: At registration, and 1, 2, 3, 6, 12 and 18 months after
|
Collected through self-assessment at the user level with an ad hoc questionnaire adapted from the general health-seeking questionnaire (GHSQ).
|
At registration, and 1, 2, 3, 6, 12 and 18 months after
|
Level of depression (for StopBlues users coming for a relative)
Time Frame: At registration
|
Collected at the user level with the Montgomery-Asberg Depression Scale (MADRS).
It has 10 questions, quoted from 0 to 6.
|
At registration
|
Intention to seek help of StopBlues users
Time Frame: At registration for users coming for a relative, and at registration and 1, 2, 3, 6, 12 and 18 months after for users coming for themselves
|
French traduction of the first question of the General Help-Seeking Questionnaire -Original Version (GHSQ).
|
At registration for users coming for a relative, and at registration and 1, 2, 3, 6, 12 and 18 months after for users coming for themselves
|
Intensity of the participation to the application and website
Time Frame: At month 9 and 18 (end of the trial)
|
Number of downloads and connections for each zip codes of local authorities included in the trial.
|
At month 9 and 18 (end of the trial)
|
Length of use to the application and website
Time Frame: At month 9 and 18 (end of the trial)
|
Time-lapse between the inscription and the last connection to the application or website.
|
At month 9 and 18 (end of the trial)
|
Proportion of StopBlues users who came to know the e-health tool through the different communication channels
Time Frame: At registration
|
Collected at the user level with a specific question: "How did you get to know about the StopBlues program?" . 1/ By public display 2/ In public places (employment center, library ...) 3/ On my city website 4/ By the press 5/ Through social networks 6/ At merchants 7/ At my pharmacist 8/ At my GP 9/ At another health professional (physiotherapist, medical specialist ...) 10/Through relationships (friends, families, neighbors ...) 11/ Other |
At registration
|
Proportion of StopBlues users who came for a relative
Time Frame: At registration
|
The proportion of users who subscribed for a relative and not for themselves.
|
At registration
|
StopBlues users with a safety plan
Time Frame: At month 9 and 18 (end of the trial)
|
The proportion of users who filled up a safety plan.
|
At month 9 and 18 (end of the trial)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Karine Chevreul, MD, PhD, Institut National de la Santé Et de la Recherche Médicale, France
Publications and helpful links
General Publications
- Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010 Mar 23;340:c332. doi: 10.1136/bmj.c332.
- Campbell MK, Piaggio G, Elbourne DR, Altman DG; CONSORT Group. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012 Sep 4;345:e5661. doi: 10.1136/bmj.e5661. No abstract available.
- Bertolote J, Fleischmann A. A global perspective on the magnitude of suicide mortality. The Oxford Textbook of Suicidology and Suicide Prevention: A Global Perspective. Oxford: Oxford University Press. Wasserman D., Wasserman C.; 2009. p. 91 98.
- Marie-Claude Mouquet, Bellamy V. Suicides et tentatives de suicide en France. Etude et Résultats. Mai 2006;(488).
- O'Dea D, Tucker S. The cost of suicide to society. Wellington: Ministry of Health. 2005.
- Kennelly B. The economic cost of suicide in Ireland. Crisis. 2007;28(2):89-94. doi: 10.1027/0227-5910.28.2.89.
- du Roscoat E, Beck F. Efficient interventions on suicide prevention: a literature review. Rev Epidemiol Sante Publique. 2013 Aug;61(4):363-74. doi: 10.1016/j.respe.2013.01.099. Epub 2013 Jul 10.
- Programme national d'actions contre le suicide 2011-2014. 2011
- Ministère des Affaires Sociales et de la Santé. Décret n° 2013-809 du 9 septembre 2013 portant création de l'Observatoire National du Suicide. 2013
- Atkinson NL, Saperstein SL, Pleis J. Using the internet for health-related activities: findings from a national probability sample. J Med Internet Res. 2009 Feb 20;11(1):e4. doi: 10.2196/jmir.1035.
- Dickerson S, Reinhart AM, Feeley TH, Bidani R, Rich E, Garg VK, Hershey CO. Patient Internet use for health information at three urban primary care clinics. J Am Med Inform Assoc. 2004 Nov-Dec;11(6):499-504. doi: 10.1197/jamia.M1460. Epub 2004 Aug 6.
- Haga SM, Drozd F, Brendryen H, Slinning K. Mamma mia: a feasibility study of a web-based intervention to reduce the risk of postpartum depression and enhance subjective well-being. JMIR Res Protoc. 2013 Aug 12;2(2):e29. doi: 10.2196/resprot.2659.
- Monshat K, Vella-Brodrick D, Burns J, Herrman H. Mental health promotion in the Internet age: a consultation with Australian young people to inform the design of an online mindfulness training programme. Health Promot Int. 2012 Jun;27(2):177-86. doi: 10.1093/heapro/dar017. Epub 2011 Mar 11.
- Allen J, Mohatt G, Fok CC, Henry D; People Awakening Team. Suicide prevention as a community development process: understanding circumpolar youth suicide prevention through community level outcomes. Int J Circumpolar Health. 2009 Jun;68(3):274-91. doi: 10.3402/ijch.v68i3.18328.
- Bean G, Baber KM. Connect: an effective community-based youth suicide prevention program. Suicide Life Threat Behav. 2011 Feb;41(1):87-97. doi: 10.1111/j.1943-278X.2010.00006.x. Epub 2011 Jan 24.
- Ono Y, Sakai A, Otsuka K, Uda H, Oyama H, Ishizuka N, Awata S, Ishida Y, Iwasa H, Kamei Y, Motohashi Y, Nakamura J, Nishi N, Watanabe N, Yotsumoto T, Nakagawa A, Suzuki Y, Tajima M, Tanaka E, Sakai H, Yonemoto N. Effectiveness of a multimodal community intervention program to prevent suicide and suicide attempts: a quasi-experimental study. PLoS One. 2013 Oct 9;8(10):e74902. doi: 10.1371/journal.pone.0074902. eCollection 2013.
- Pearson A, Saini P, Da Cruz D, Miles C, While D, Swinson N, Williams A, Shaw J, Appleby L, Kapur N. Primary care contact prior to suicide in individuals with mental illness. Br J Gen Pract. 2009 Nov;59(568):825-32. doi: 10.3399/bjgp09X472881.
- Hegerl U, Althaus D, Schmidtke A, Niklewski G. The alliance against depression: 2-year evaluation of a community-based intervention to reduce suicidality. Psychol Med. 2006 Sep;36(9):1225-33. doi: 10.1017/S003329170600780X. Epub 2006 May 17.
- Chabaud F, Debarre J, Serazin C, Bouet R, Vaiva G, Roelandt JL. [Study of population profiles in relation to the level of suicide risk in France: Study "Mental health in the general population"]. Encephale. 2010;36(3 Suppl):33-8. doi: 10.1016/S0013-7006(10)70016-6. French.
- Schmidtke A, Bille-Brahe U, DeLeo D, Kerkhof A, Bjerke T, Crepet P, Haring C, Hawton K, Lonnqvist J, Michel K, Pommereau X, Querejeta I, Phillipe I, Salander-Renberg E, Temesvary B, Wasserman D, Fricke S, Weinacker B, Sampaio-Faria JG. Attempted suicide in Europe: rates, trends and sociodemographic characteristics of suicide attempters during the period 1989-1992. Results of the WHO/EURO Multicentre Study on Parasuicide. Acta Psychiatr Scand. 1996 May;93(5):327-38. doi: 10.1111/j.1600-0447.1996.tb10656.x.
- Réseau OSCOUR® / Surveillance syndromique - SurSaUD® / Veille et alerte / Dossiers thématiques / Accueil [Internet]. Disponible sur: http://www.invs.sante.fr/Dossiers-thematiques/Veille-et-alerte/Surveillance-syndromique-SurSaUD-R/Reseau-OSCOUR-R
- HAS. Choix méthodologiques pour l'évaluation économique à la HAS. 2011
- Turmaine K, Dumas A, Chevreul K; PRINTEMPS Consortium. Conditions for the Successful Integration of an eHealth Tool "StopBlues" Into Community-Based Interventions in France: Results From a Multiple Correspondence Analysis. J Med Internet Res. 2022 Apr 22;24(4):e30218. doi: 10.2196/30218.
- Gandre C, Le Jeannic A, Vinet MA, Turmaine K, Courtet P, Roelandt JL, Vaiva G, Giraudeau B, Alberti C, Chevreul K. The PRINTEMPS study: protocol of a cluster-randomized controlled trial of the local promotion of a smartphone application and associated website for the prevention of suicidal behaviors in the adult general population in France. Trials. 2020 Jun 22;21(1):553. doi: 10.1186/s13063-020-04464-2.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- C 15-45
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anxiety Disorders
-
Prisma Health-UpstateCompletedAnxiety | Anxiety, Separation | Separation Anxiety | Anxiety Generalized
-
Ann & Robert H Lurie Children's Hospital of ChicagoUniversity of California, Los Angeles; University of CincinnatiRecruitingAnxiety, Separation | Anxiety, Social | Anxiety, GeneralizedUnited States
-
AstraZenecaCompletedAnxiety Disorders | Anxiety | Anxiety Neuroses | Anxiety StatesUnited States
-
Nazife Begüm KARANCompletedDental Anxiety | Sedative; Anxiety DisorderTurkey
-
Eli Lilly and CompanyCompletedAnxiety Neuroses | Anxiety States, Neurotic | Neuroses, AnxietyUnited States, Mexico, South Africa
-
Loyola UniversityCompletedAnxiety | Anxiety State | Procedural AnxietyUnited States
-
West University of TimisoaraUnknownAnxiety Disorder/Anxiety StateRomania
-
Yale UniversityNational Institute of Mental Health (NIMH)Active, not recruitingGeneralized Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood | Social Anxiety Disorder of ChildhoodUnited States
-
Queen's UniversityActive, not recruitingGeneralized Anxiety Disorder | AnxietyCanada
-
ProofPilotFisher WallaceActive, not recruitingGeneralized Anxiety Disorder | Anxiety | Generalized AnxietyUnited States
Clinical Trials on Promotion of the e-health tool by local authorities
-
Kafkas UniversityRecruitingEmotional Disorder | Premenstrual Syndrome | Perceived StressTurkey
-
University of California, San FranciscoNational Cancer Institute (NCI); Dana-Farber Cancer Institute; University of... and other collaboratorsRecruitingKidney Cancer | Renal Cell Carcinoma | Breast Cancer | Ovarian Cancer | Rectal Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Colon CancerUnited States
-
Alison GalbraithNational Institute on Aging (NIA); Massachusetts Institute of Technology; Harvard... and other collaboratorsCompletedno Specific Condition Targeted | Use of a Price Transparency ToolUnited States
-
Burnasyan Federal Medical Biophysical CenterCompletedPneumonia | Septic Shock | Hypoxemia | Acute Respiratory Insufficiency | Acute Respiratory Tract InfectionRussian Federation
-
Ankara UniversityEnrolling by invitation
-
Fundació Sant Joan de DéuFondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; University of York; Universidad... and other collaboratorsNot yet recruitingDepression | Stress | Insomnia | Anxiety
-
Eskisehir Osmangazi UniversityRecruitingStress Perception, Psychological Resilience, Compassion FatigueTurkey
-
Daren K. HeylandTerminated
-
Kettering Health NetworkOhio UniversityCompletedKangaroo Care | Prenatal Education | Video | Skin-to-skinUnited States
-
University of Alabama at BirminghamUniversidade Estadual de LondrinaRecruiting